Hematology papers
Pofolia’s corpus holds 101 papers from Hematology (2012–2026), each with a short summary. Below, the 20 most-cited, then the most recently added.
At a glance
- Most cited: The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia (2016, 10,237 citations).
- The 20 papers listed have 81,101 citations between them.
- 18 of the 18 with a known journal quartile appeared in a Q1 journal.
- 15 have a free full text (open access).
- Most frequent journals: New England Journal of Medicine, Blood, American Journal of Nephrology.
- Published between 2012 and 2022.
Most cited
Ranked by citation count. Because citations accumulate over time, this list naturally leans towards work published a few years ago; for where the field is now, see “recently added”. How to read the signals
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Blood · 2016 · Q1 · SJR 5.00 · FWCI 662.25 · 10,237 citations · Open access
The 2016 revision of the World Health Organization (WHO) classification for myeloid neoplasms and acute leukemia incorporates new biomarker data from gene expression analysis and next-generation sequencing.
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Blood · 2016 · Q1 · SJR 5.00 · FWCI 253.04 · 5,899 citations · Open access
Updated European LeukemiaNet (ELN) recommendations for adult acute myeloid leukemia (AML) diagnosis and management have been released, incorporating recent genomic discoveries and advances in minimal residual disease (MRD) detection.
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
Biology of Blood and Marrow Transplantation · 2014 · FWCI 204.80 · 5,418 citations · Open access
The 2014 NIH consensus refines diagnostic and staging criteria for chronic graft-versus-host disease (GVHD), maintaining the 2005 framework but improving specificity for prognosis, treatment guidance, and clinical trial eligibility.
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
New England Journal of Medicine · 2013 · Q1 · SJR 18.00 · FWCI 211.41 · 5,182 citations · Open access
Adult acute myeloid leukemia (AML) genomes are characterized by a low mutation burden, with an average of only 13 mutations per patient, of which 5 are recurrently mutated.
IL-6 in Inflammation, Immunity, and Disease
Cold Spring Harbor Perspectives in Biology · 2014 · Q1 · SJR 3.00 · 4,995 citations · Open access
Interleukin-6 (IL-6) is crucial for host defense against infection and injury, but its dysregulated synthesis drives chronic inflammation and autoimmunity.
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
American Journal of Nephrology · 2017 · Q1 · SJR 1.00 · FWCI 252.22 · 4,817 citations
Pharmacologic activation of hypoxia-inducible factors (HIFs) offers a novel approach to treating anemia in chronic kidney disease (CKD) by stimulating erythropoiesis through a transient pseudo-hypoxic state.
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
New England Journal of Medicine · 2014 · Q1 · SJR 18.00 · FWCI 129.16 · 4,781 citations · Open access
Somatic mutations in blood cells, termed age-related clonal hematopoiesis, are detectable in nearly 10-18% of individuals over 70 and are linked to significantly increased risks of hematologic cancer, all-cause mortality, and cardiovascular events.
Genomic Classification and Prognosis in Acute Myeloid Leukemia
New England Journal of Medicine · 2016 · Q1 · SJR 18.00 · FWCI 228.64 · 4,402 citations · Open access
A large-scale genomic analysis of 1540 acute myeloid leukemia (AML) patients has identified 11 distinct molecular subgroups, revealing that combinations of gene mutations, rather than single mutations, significantly impact disease progression and patient outcomes.
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Leukemia · 2022 · Q1 · SJR 3.00 · FWCI 509.65 · 3,967 citations · Open access
The 5th edition of the WHO Classification of Haematolymphoid Tumours refines diagnostic criteria for myeloid and histiocytic/dendritic neoplasms, emphasizing therapeutically actionable biomarkers and molecular biology.
Hematological Problems in Pediatric Intensive Care
Pediatric and adolescent medicine · 2013 · FWCI 457.10 · 3,517 citations
Desmopressin (DDAVP) has been a safe and cost-effective treatment for children with von Willebrand disease and Hemophilia A for nearly 35 years, significantly reducing exposure to plasma-derived products.
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
New England Journal of Medicine · 2014 · Q1 · SJR 18.00 · FWCI 113.48 · 3,516 citations · Open access
DNA sequencing readily detects clonal hematopoiesis with somatic mutations, a condition found in 10% of individuals over 65, significantly increasing their risk of developing hematologic cancers.
Acute Myeloid Leukemia
New England Journal of Medicine · 2015 · Q1 · SJR 18.00 · FWCI 117.54 · 3,393 citations
Recent biological discoveries in acute myeloid leukemia (AML) have deepened our understanding of its classification, though these insights have yet to significantly alter current treatment approaches.
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Blood · 2012 · Q1 · SJR 5.00 · FWCI 91.79 · 3,155 citations · Open access
A new prognostic model, the IPSS-R, has been developed using a larger dataset (n=7012) to more precisely predict outcomes for myelodysplastic syndromes (MDS) patients.
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
Blood · 2022 · Q1 · SJR 5.00 · FWCI 386.60 · 3,068 citations · Open access
The European LeukemiaNet (ELN) has updated its 2022 recommendations for diagnosing and managing adult acute myeloid leukemia (AML), incorporating recent advances in molecular pathogenesis, genomic diagnostics, and novel therapies.
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
New England Journal of Medicine · 2020 · Q1 · SJR 18.00 · FWCI 164.38 · 2,803 citations · Open access
Adding venetoclax to azacitidine significantly improved survival and remission rates in older or co-morbid patients with acute myeloid leukemia (AML) ineligible for intensive chemotherapy.
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Blood · 2022 · Q1 · SJR 5.00 · FWCI 345.64 · 2,739 citations · Open access
A new International Consensus Classification (ICC) for myeloid neoplasms and acute leukemias has been developed, integrating morphologic, clinical, and genomic data to define distinct disease entities.
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
New England Journal of Medicine · 2017 · Q1 · SJR 18.00 · FWCI 117.69 · 2,639 citations
Clonal hematopoiesis of indeterminate potential (CHIP), a common condition in older adults, is linked to a nearly doubled risk of coronary heart disease in humans and accelerated atherosclerosis in mice.
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
New England Journal of Medicine · 2017 · Q1 · SJR 18.00 · FWCI 128.48 · 2,209 citations · Open access
Adding the kinase inhibitor midostaurin to standard chemotherapy significantly improved overall survival for patients with acute myeloid leukemia (AML) and a FLT3 mutation.
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
Journal of Clinical Oncology · 2015 · Q1 · SJR 4.00 · FWCI 73.19 · 2,189 citations · Open access
A new Revised International Staging System (R-ISS) for multiple myeloma effectively stratifies patients into three risk groups based on existing ISS staging, chromosomal abnormalities, and lactate dehydrogenase levels.
Genomewide Association Study of Severe Covid-19 with Respiratory Failure
New England Journal of Medicine · 2020 · Q1 · SJR 18.00 · FWCI 211.29 · 2,175 citations
A genome-wide association study identified a genetic locus in the 3p21.31 gene cluster strongly associated with severe COVID-19 leading to respiratory failure.
Recently added
HemaViT: transformer-based deep learning for automated non-invasive anemia detection using conjunctival imaging
Scientific Reports · 2026 · Q1
HemaViT, a novel transformer-based deep learning framework, achieves 95.8% average accuracy for automated, non-invasive anemia detection using conjunctival images.
An evaluation of denecimig for bleeding prophylaxis in hemophilia A
Expert Opinion on Biological Therapy · 2026 · Q1 · SJR 1.00
Denecimig (Mim8), a novel bispecific antibody, shows potent bleed prevention in hemophilia A across age groups and inhibitor status, offering flexible subcutaneous prophylaxis.
Preliminary exploration of tissue oxygen saturation index using near-infrared spectroscopy in two infants of neonatal catheter-associated venous thrombosis
BMC Pediatrics · 2026 · Q1
Near-infrared spectroscopy (NIRS) successfully monitored limb tissue oxygen saturation index (TOI) in two infants with catheter-related venous thrombosis (CRT), showing TOI normalization after thrombolysis indicated restored venous patency.
Fast-Dissolving and Highly Soluble Dasatinib Multicomponent Crystals Efficiently Inhibit Leukemia Cell Viability
ACS Omega · 2026 · Q1
New multicomponent crystalline forms (MCCs) of dasatinib (DAS) achieved up to 1470-fold higher aqueous solubility and 312-fold increased intrinsic dissolution rate compared to the parent drug, leading to enhanced cytotoxicity against tumor cells.
The effect of HIF-PHIs on anemia in non-dialysis-dependent CKD patients: a systematic review and network meta-analysis
BMC Nephrology · 2026 · Q1
Roxadustat and enarodustat significantly increased hemoglobin levels in non-dialysis-dependent CKD patients compared to placebo, with roxadustat showing the largest overall increase (MD = 1.66). HIF-PHIs generally decreased transferrin saturation and ferritin while increasing total iron-binding capacity.
The association between Oxidative Balance Score and anemia in adults
Medicine · 2026 · Q2
Adults with the highest tertile of the Oxidative Balance Score (OBS) had 30% lower odds of anemia compared to those with the lowest tertile (OR=0.70).
Development of multiplex real-time polymerase chain reaction assay for the detection of leukemia-associated translocation genes
Tzu Chi Medical Journal · 2026 · Q2
A multiplex real-time PCR assay was developed to simultaneously detect seven common leukemia-associated chromosomal translocations (TCF3::PBX1, ETV6::RUNX1, PML::RARA, KMT2A::AFF1, BCR::ABL1, CBFB::MYH11, and RUNX1::RUNX1T1) with an average detection limit of 10^4 copies/mL.
Anthracycline and antimetabolite, trigger distinct resistance mechanisms in TP53mut AML
Cell Death Discovery · 2026 · Q1 · SJR 2.00
TP53-mutated Acute Myeloid Leukemia (AML) exhibits distinct resistance mechanisms to anthracycline and antimetabolite chemotherapies, posing a significant challenge for treatment.
Journals in this field
The journals that publish most of this field’s papers. Quartile (Q1–Q4), SJR and h-index are from SCImago Journal Rank; “in this field” is how many of the journal’s pooled papers belong here. What is a Q1 journal? · What is the h-index?
| Journal | Quartile | SJR | h-index | In this field | Summaries |
|---|---|---|---|---|---|
| New England Journal of Medicine | Q1 | 18.00 | 1275 | 29 | 376 |
| Blood | Q1 | 5.00 | 556 | 12 | 21 |
| Leukemia | Q1 | 3.00 | 235 | 4 | 5 |
| Science | Q1 | 10.00 | 1433 | 3 | 268 |
| Physiological Reviews | Q1 | 11.00 | 417 | 2 | 28 |
| Journal of Clinical Oncology | Q1 | 4.00 | 666 | 2 | 38 |
| Blood Advances | Q1 | 3.00 | 110 | 2 | 7 |
| BMC Cancer | Q2 | 1.00 | 180 | 2 | 3 |
Every journal in Hematology (Q1–Q4) →
Add this field to your daily feed
Pick your interests and new work in your area arrives every day, summarised. Full summaries live in the app.
Open the app